Repository logo
 

The Nucleosome Remodelling and Deacetylation complex suppresses transcriptional noise during lineage commitment.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Burgold, Thomas 
Barber, Michael 
Kloet, Susan 
Cramard, Julie 
Gharbi, Sarah 

Abstract

Multiprotein chromatin remodelling complexes show remarkable conservation of function amongst metazoans, even though components present in invertebrates are often found as multiple paralogous proteins in vertebrate complexes. In some cases, these paralogues specify distinct biochemical and/or functional activities in vertebrate cells. Here, we set out to define the biochemical and functional diversity encoded by one such group of proteins within the mammalian Nucleosome Remodelling and Deacetylation (NuRD) complex: Mta1, Mta2 and Mta3. We find that, in contrast to what has been described in somatic cells, MTA proteins are not mutually exclusive within embryonic stem (ES) cell NuRD and, despite subtle differences in chromatin binding and biochemical interactions, serve largely redundant functions. ES cells lacking all three MTA proteins exhibit complete NuRD loss of function and are viable, allowing us to identify a previously unreported function for NuRD in reducing transcriptional noise, which is essential for maintaining a proper differentiation trajectory during early stages of lineage commitment.

Description

Keywords

ES Cell, NuRD, chromatin, lineage commitment, transcription, Animals, Cell Differentiation, Cell Lineage, Cells, Cultured, Cellular Reprogramming, DNA-Binding Proteins, Embryo, Mammalian, Gene Expression Regulation, Developmental, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Mice, Mice, Knockout, Mouse Embryonic Stem Cells, Neoplasm Proteins, Repressor Proteins, Signal-To-Noise Ratio, Trans-Activators, Transcription Factors, Transcription, Genetic

Journal Title

EMBO J

Conference Name

Journal ISSN

0261-4189
1460-2075

Volume Title

38

Publisher

Springer Science and Business Media LLC

Rights

All rights reserved
Sponsorship
Wellcome Trust (098021/Z/11/Z)
Wellcome Trust (091484/Z/10/Z)
Biotechnology and Biological Sciences Research Council (BB/P009867/1)
Wellcome Trust (097922/Z/11/Z)
Wellcome Trust (203151/Z/16/Z)
European Commission (277899)
Medical Research Council (MC_PC_12009)
Funding to the BH and MV labs was provided through EU FP7 Integrated Project “4DCellFate” (277899). The BH lab further benefitted from a Wellcome Trust Senior Fellowship (098021/Z/11/Z) and from core funding to the Cambridge Stem Cell Institute from the Wellcome Trust and Medical Research Council (097922/Z/11/Z and 203151/Z/16/Z). The Vermeulen lab is part of the Oncode Institute, which is partly funded by the Dutch Cancer Society (KWF).
Relationships
Is derived from: